The Belgian university will use the WaferGen system in validating a biomarker signature for neuroblastoma in children, as well as other applications.
Researchers from Australia and the US have used genotyping, microRNA analysis, and mitochondrial and transcriptome sequencing to tackle a transmissible Tasmanian devil cancer.
American and Serbian researchers have identified telltale miRNA changes in the saliva of individuals with oral cancer — a finding that they say may eventually yield saliva-based oral cancer diagnostic tests.
Rosetta Genomics, Alnylam Pharmaceuticals, Massachusetts Institute of Technology
The firm published data from a study showing that the same biomarker used in its miRNA-based test for squamous lung cancer provided 96 percent sensitivity.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.